Please ensure Javascript is enabled for purposes of website accessibility Venture Fund - Janus Henderson Investors - US Advisor
For Financial Professionals in the US

Venture Fund Holdings

Full Portfolio Holdings

(As of 05/31/2025)

% OF INVESTMENTS
Stride Inc 2.97
SS&C Technologies Holdings Inc 2.34
Descartes Systems Group Inc 2.30
OSI Systems Inc 2.23
LPL Financial Holdings Inc 2.11
Sensient Technologies Corp 1.94
SPX Technologies Inc 1.75
Core & Main Inc 1.69
Shift4 Payments Inc 1.64
Bancorp Inc 1.49
Casey's General Stores Inc 1.47
Rentokil Initial PLC (ADR) 1.40
Broadridge Financial Solutions Inc 1.40
Paylocity Holding Corp 1.36
Zurn Elkay Water Solutions Corp 1.32
Euronet Worldwide Inc 1.31
Oddity Tech Ltd 1.29
Aramark 1.28
Globus Medical Inc 1.26
ITT Inc 1.24
Tyler Technologies Inc 1.14
Chart Industries Inc 1.07
Gildan Activewear Inc 1.06
Lantheus Holdings Inc 1.04
ICU Medical Inc 1.04
Valvoline Inc 1.04
Perimeter Solutions Inc 1.03
Monarch Casino & Resort Inc 1.02
Vertex Inc 1.00
Alamo Group Inc 0.99
Gates Industrial Corp PLC 0.99
Ligand Pharmaceuticals Inc 0.98
Atlanta Braves Holdings Inc 0.98
Blackbaud Inc 0.95
Magnolia Oil & Gas Corp 0.94
Glaukos Corp 0.93
Enpro Inc 0.92
Simulations Plus Inc 0.90
Constellium SE 0.89
Ascendis Pharma A/S (ADR) 0.85
ATS Corp 0.85
CSW Industrials Inc 0.84
CACI International Inc 0.83
Madrigal Pharmaceuticals Inc 0.83
AvidXchange Holdings Inc 0.82
EnerSys 0.82
Baldwin Insurance Group Inc 0.82
BellRing Brands Inc 0.82
CRA International Inc 0.77
HealthEquity Inc 0.76
Standard Aero Inc 0.75
Insmed Inc 0.75
Loar Holdings Inc 0.75
Mirum Pharmaceuticals Inc 0.72
Verona Pharma PLC (ADR) 0.71
Doximity Inc 0.70
Avidity Biosciences Inc 0.70
Novanta Inc 0.70
Innodata Inc 0.69
WEX Inc 0.68
Bel Fuse Inc 0.68
Innospec Inc 0.68
Janus International Group Inc 0.66
Halozyme Therapeutics Inc 0.65
RLI Corp 0.64
Alkami Technology Inc 0.64
Kinaxis Inc 0.63
STERIS PLC 0.63
REVOLUTION Medicines Inc 0.62
Bridgebio Pharma Inc 0.62
Hamilton Lane Inc 0.62
Napco Security Technologies Inc 0.61
FirstService Corp 0.61
Nice Ltd (ADR) 0.60
UL Solutions Inc 0.59
Ziff Davis Inc 0.56
Consensus Cloud Solutions Inc 0.55
AST SpaceMobile Inc 0.55
Waystar Holding Corp 0.54
Colliers International Group Inc 0.54
Clearwater Analytics Holdings Inc 0.54
Vaxcyte Inc 0.54
ON Semiconductor Corp 0.54
CECO Environmental Corp 0.53
PTC Therapeutics Inc 0.53
Asure Software Inc 0.53
Soleno Therapeutics Inc 0.52
Kornit Digital Ltd 0.51
Alight Inc 0.51
MSA Safety Inc 0.51
MACOM Technology Solutions Holdings Inc 0.50
Portillo's Inc 0.47
Procore Technologies Inc 0.47
Avadel Pharmaceuticals PLC 0.45
PDF Solutions Inc 0.44
Brady Corp 0.43
Walker & Dunlop Inc 0.41
Montrose Environmental Group Inc 0.41
Dream Finders Homes Inc 0.41
Mama's Creations Inc 0.38
89bio Inc 0.38
Repay Holdings Corp 0.38
Beta Bionics Inc 0.37
California Resources Corp 0.35
Apartment List Inc 0.35
Akero Therapeutics Inc 0.34
Nova Ltd 0.34
Inspired Entertainment Inc 0.34
NeoGenomics Inc 0.32
Arcellx Inc 0.31
Computer Modelling Group Ltd 0.30
Thor Industries Inc 0.30
Crinetics Pharmaceuticals Inc 0.30
Cimpress PLC 0.30
Ideaya Biosciences Inc 0.29
Weatherford International PLC 0.29
Manchester United Plc 0.27
Biohaven Ltd 0.26
Xenon Pharmaceuticals Inc 0.26
Janux Therapeutics Inc 0.23
Centessa Pharmaceuticals PLC (ADR) 0.23
Structure Therapeutics Inc (ADR) 0.19
Disc Medicine Inc 0.16
Loadsmart Inc 0.15
Travere Therapeutics Inc 0.12
Edgewise Therapeutics Inc 0.09
OmniAb Inc 0.05
Loadsmart Inc 0.05
IntelyCare Inc 0.04
Claris Ventures SGR SPA 0.02
TVTX US 20MAR26 Call0 (AMERICAN PHYSICAL) MS OTC 22.5 0.01
Claris Ventures SGR SPA, 8.00%, 07/31/26 0.01
OmniAb Inc 0.00
OmniAb Inc 0.00
ASTS US 16Jan26 Call (AMERICAN PHYSICAL) MS OTC 55 -0.01
Cash & Equivalents 1.90
Janus Henderson publishes this listing of securities held as of the most recently available disclosure period, which varies depending on the portfolio. Any portion of holdings may be excluded from publication when deemed in the best interest of the portfolio. Securities are reported at market value.
The portfolio data and its presentation here is based on the investment book of record and may differ from the accounting book of record and complete schedules of investments in regulatory filings due to differing accounting and reporting standards.